Johnson & Johnson

Johnson & Johnson is an American multinational pharmaceutical and medical technologies corporation founded in 1886, with Janssen Pharmaceuticals subsidiary launching three-year research collaboration with Qu&Co in 2021 to develop and test quantum computational algorithms and software for pharmaceutical R&D applications. Janssen employed Qu&Co's QUBEC platform for quantum computational chemistry and materials science, testing algorithms on quantum processors. In 2024, Johnson & Johnson partnered with Pasqal working to demonstrate practical benefits of quantum computing for drug discovery problems. Johnson & Johnson is among biggest pharma industry players submitting quantum computing patents alongside Merck, Roche, and Amgen. The company uses quantum computing for molecular simulations, optimization problems in drug discovery, and computational chemistry applications. Johnson & Johnson serves global pharmaceutical market requiring quantum-enhanced drug discovery, molecular modeling, and computational chemistry for developing treatments for cancer, Alzheimer's, Parkinson's, and other conditions accelerating path from discovery to clinical trials.